Essential Partners’s Exact Sciences EXAS Stock Holding History

Essential Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,173	Closed	-$932K	–	2887
2025 Q4	$932K	Buy	9,173 +6,126	+201%	+$492K	0.29%	95
2025 Q3	$167K	Buy	3,047 +237	+8%	+$11.8K	0.06%	351
2025 Q2	$149K	Buy	+2,810	New	+$143K	0.06%	312

Other funds holding EXAS

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Essential Partners's EXAS Position: Q1 2026 in Review

Essential Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9,173 shares — an estimated $932K sold.

Essential Partners first reported a position in EXAS in Q2 2025 and held it in 3 quarters. The position peaked at $932K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Essential Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Essential Partners sold 9,173 Exact Sciences shares in Q1 2026, an estimated $932K.
Essential Partners first reported a position in Exact Sciences in Q2 2025 and held it in 3 quarters.
Essential Partners's Exact Sciences position peaked at $932K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Essential Partners's 13F filing for Q1 2026, filed 21 May 2026.